IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients – a cohort studyGaya Spolverato, Salvatore Pucciarelli, Luca Facci et al.|International Journal of Surgery|2023Cited by 11
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Chiara Cipollari, Melania Scarpa et al.|Cancer|2024Cited by 8
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Monica Ortenzi, Matteo Fassan et al.|British journal of surgery|2023Cited by 4
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancerGiulia Becherucci, Daunia Verdi, Cesare Ruffolo et al.|Surgery|2024Cited by 2
67 IMMUNOREACT 9: METACHRONOUS RECTAL CANCER ARE FREQUENTLY FROM PREVIOUS RECTAL OR SIGMOID CANCER AND HAVE A LOW INFILTRATION OF CD8+ T CELLSBeatrice Salmaso, Marco Scarpa, Melania Scarpa et al.|Gastroenterology|2023Cited by 0